13D/13G Filings - Travere Therapeutics Inc. (TVTX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-11
4:31 pm
Purchase
2020-12-31 13G Travere Therapeutics, Inc.
TVTX
Integrated Core Strategies (US) LLC 727,176
1.400%
727,176increase
(New Position)
Filing
History
2021-02-10
11:57 am
Purchase
2020-12-31 13G Travere Therapeutics, Inc.
TVTX
The Vanguard Group 3,404,443
6.670%
3,404,443increase
(New Position)
Filing
History
2021-02-03
8:55 pm
Purchase
2020-12-31 13G Travere Therapeutics, Inc.
TVTX
Manulife Financial Corporation 2,157,055
11.000%
2,157,055increase
(New Position)
Filing
History
2021-02-01
08:17 am
Purchase
2020-12-31 13G Travere Therapeutics, Inc.
TVTX
BlackRock Inc.
BLK
4,825,174
9.500%
4,825,174increase
(New Position)
Filing
History
2021-01-04
4:05 pm
Purchase
2020-12-24 13G Travere Therapeutics, Inc.
TVTX
ADAGE CAPITAL PARTNERS GP L.L.C. 2,850,000
5.580%
2,850,000increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, 3